2004 Annual Meeting | Neurologic Complications of Systemic Cancer

Date Friday 04/30/04

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Josep O. Dalmau, MD, PhD, FAAN

Topic(s) Neuro-oncology

Learning Objectives Upon completion:
Participants should be able to diagnose and manage patients with brain metastases, metastatic plexopathy, cord compression, and neurological complications of radiation and chemotherapy; and to promptly recognize paraneoplastic neurologic disorders.

CME Available No CME available

Program Level Introductory

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
09:00 AM - 09:45 AM		Diagnosis and Management of Brain Metastases Roy A. Patchell, MD
09:45 AM - 10:30 AM		Diagnosis and Management of Metastatic Plexopathy and Spinal Cord Compression Kurt A. Jaeckle, MD, FAAN
10:30 AM - 10:45 AM		Break
10:45 AM - 11:30 AM		Neurologic Complications of Chemotherapy and Radiation Therapy Edward J. Dropcho, MD
11:30 AM - 12:15 PM		Paraneoplastic Neurologic Syndromes Josep O. Dalmau, MD, PhD, FAAN
12:15 PM - 12:45 PM		Case Presentations and Panel Discussion Josep O. Dalmau, MD, PhD, FAAN, Kurt A. Jaeckle, MD, FAAN, Edward J. Dropcho, MD, Roy A. Patchell, MD

Faculty Disclosures
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Kurt A. Jaeckle, MD, FAAN	Dr. Jaeckle has stock in Entegrion, Inc.
Edward J. Dropcho, MD	No disclosure on file
Roy A. Patchell, MD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��